Show simple item record

dc.contributor.authorİLHAN, OSMAN
dc.contributor.authorLeblond, Veronique
dc.contributor.authorÜNAL, ALİ
dc.contributor.authorLaribi, Kamel
dc.contributor.authorMeddeb, Balkis
dc.contributor.authorMoreno, Carol
dc.contributor.authorOertel, Stephan H. K.
dc.contributor.authorMichallet, Anne-Sophie
dc.contributor.authorAktan, Melih
dc.contributor.authorRaposo, Joao
dc.contributor.authorJohansson, Peter
dc.contributor.authorWidenius, Tom
dc.contributor.authorSchuh, Anna
dc.contributor.authorRassam, Saad M. B.
dc.date.accessioned2021-03-03T07:39:59Z
dc.date.available2021-03-03T07:39:59Z
dc.identifier.citationLeblond V., Laribi K., İLHAN O., Aktan M., ÜNAL A., Rassam S. M. B. , Schuh A., Widenius T., Johansson P., Raposo J., et al., "Rituximab in Combination with Bendamustine or Chlorambucil for Treating Patients with Chronic Lymphocytic Leukemia: Interim Results of a Phase IIIb Study (MaBLe).", 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Georgia, Amerika Birleşik Devletleri, 8 - 11 Aralık 2012, cilt.120
dc.identifier.othervv_1032021
dc.identifier.otherav_132fb0cb-5e92-4feb-869b-d5ebbf9df4ae
dc.identifier.urihttp://hdl.handle.net/20.500.12627/18356
dc.identifier.urihttps://doi.org/10.1182/blood.v120.21.2744.2744
dc.language.isoeng
dc.subjectİç Hastalıkları
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectHEMATOLOJİ
dc.subjectHematoloji
dc.subjectDahili Tıp Bilimleri
dc.titleRituximab in Combination with Bendamustine or Chlorambucil for Treating Patients with Chronic Lymphocytic Leukemia: Interim Results of a Phase IIIb Study (MaBLe).
dc.typeBildiri
dc.contributor.departmentAssistance Publique Hopitaux Paris (APHP) , ,
dc.identifier.volume120
dc.contributor.firstauthorID140794


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record